Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Blood Sugar Archives
Print | Email | Share | Comments (0)

Artificial Pancreas Project Launched

Jun 1, 2000

The Disetronic Group has initiated and received approval for the development of an innovative new insulin delivery system with integrated monitoring of blood sugar.

The goal of the ADICOL project (Advanced Insulin Infusion with a Control Loop) is to develop a kind of artificial pancreas to the prototype stage, so that the daily insulin dosage can be administered to people with diabetes practically, automatically and exactly in the required amounts.

The ADICOL system consists of a glucose sensor and insulin pump. The sensor is implanted under the skin to continuously measure and display the blood sugar concentration. If the measurement exceeds or falls short of the critical concentration, the sensor emits an alarm. With special software the sensor controls the insulin pump to dispense precisely the dosage of insulin needed.

Bruno Reihl, head of research and development for The Disetronic Group, expects the ADICOL project to result in substantial advances in diabetes care. According to The Disetronic Group, the universities of Graz and Perugia will collaborate as clinical centers as well as the Fraunhofer Institute for Biomedical Engineering and SensLab GmbH, both of Germany, for sensor technology. The City University of London, and Judex, a Danish firm, will also collaborate for expertise in control algorithms and simulation models.

For more information, contact David Chadwick, director of regulatory affairs at The Disetronic Group at 612-795-5200.


Categories: Artificial Pancreas, Blood Sugar, Diabetes, Diabetes, Insulin, Insulin Pumps, Islet & Pancreas Transplant



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Jun 1, 2000

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.